Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Textual)

v3.10.0.1
Stockholders' Equity (Details Textual) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2018
Mar. 12, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common Stock, Shares, Issued 26,263,354   25,236,255
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 3,000,000    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 5,000,000    
Share-based Compensation Award, Tranche One [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 50.00%    
Share-based Compensation Award, Tranche Two [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 50.00%    
Incentive Plan 2016 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 2,000,000    
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 2,915,325    
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated Share-based Compensation Expense $ 1.1    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 50,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 2 years 9 months 18 days    
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated Share-based Compensation Expense $ 4.0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 579,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 2 years    
Two Consultant [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 200,000    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 4 years    
Employee Stock Option [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated Share-based Compensation Expense $ 1.2    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 1 year 4 months 24 days    
Employee Stock Option [Member] | Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 379,000    
Fortress Biotech, Inc [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common Stock, Shares, Issued   834,756  
Percentage of issued shares in diluted outstanding shares   2.50%